- Comprehensive portfolio for biologics and the challenges of the latest therapies
- Gx Elite platform - highest quality and best protection for
injectable drugs - Innovative drug delivery systems for self-administration
- Gerresheimer at CPHI 2024 in Hall 20, Stand 20B1
Düsseldorf/Milan, October 2, 2024. Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech and cosmetics industries, will be presenting its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions at this year's CPHI. Gerresheimer's presence at the trade fair will focus on specialized primary packaging solutions and delivery systems for therapeutic areas such as vaccinations, diabetes and obesity, ophthalmology and immunology.
With its comprehensive portfolio and many years of expertise, Gerresheimer offers the right solution for every drug - including sensitive biopharmaceuticals - from mRNA-based vaccines and cancer therapies to RNAi-based ophthalmic drugs and GLP1 drugs for the treatment of diabetes and obesity. With Gx Elite syringes, Gx Elite cartridges and Gx Elite injection vials, for example, Gerresheimer offers the highest quality and best protection for sensitive injectable drugs. With the Gx Inbeneo autoinjector and the Gx SensAiron-body drug delivery device, Gerresheimer is presenting two innovative platform solutions that support the trend towards home therapy. Gerresheimer will be presenting its solutions at CPHI in Milan from October 8 to 10, 2024 in Hall 20 at Stand 20B1. Gerresheimer's experts will also be providing insights into current trends with presentations in the Packaging Innovation Theatre.
